Clinical Trials Browser

NCT04955808 2026-03-18

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

Recruiting

324 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

ELEPHAS-04

SEEK

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

cfDNA Methylation for Liver Cancer Recurrence Detection

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

ISTAR-01

Bio-Delta

Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

BLOOD-TACE-M

SWITCH

Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients

Evaluation of Resection Techniques for Pancreatic Tumors

RESPECT

LiverINSPECT

NISTIPS

BLOOD-TACE-P

GENDER-HCC-MET

Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

RASEREM

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

VIGILANT

CoVaCheck

Liver and Biliary Tumor Tissue Registry

IMreal

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC

CCANED-CIPHER

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

ELEPHAS-02

DETECT

DETECT-HCC

IMMUNOCELL

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

EVOLVE

IMMUNOGLYPIC